Mind Medicine (MindMed) I... (MNMD)
NASDAQ: MNMD
· Real-Time Price · USD
6.82
-0.32 (-4.48%)
At close: Jun 17, 2025, 2:05 PM
-4.48% (1D)
| Bid | 6.81 |
| Market Cap | 515.52M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -77.63M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -9.1 |
| Forward PE | -4.62 |
| Analyst | Buy |
| Ask | 6.83 |
| Volume | 508,343 |
| Avg. Volume (20D) | 1,145,053 |
| Open | 7.10 |
| Previous Close | 7.14 |
| Day's Range | 6.82 - 7.16 |
| 52-Week Range | 4.70 - 10.44 |
| Beta | 2.88 |
About MNMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MNMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MNMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
+8.42%
Mind Medicine and Compass Pathways shares are trad...
Unlock content with
Pro Subscription
4 months ago
+7.68%
Mind Medicine shares are trading higher after Evercore ISI Group initiated coverage on the stock with an Outperform rating and announced a $23 price target.
1 month ago · seekingalpha.com
Mind Medicine (MindMed) Inc. (MNMD) Q1 2025 Earnings Call TranscriptMind Medicine (MindMed) Inc. (NASDAQ:MNMD ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - Chief Executive ...
1 month ago · businesswire.com
MindMed to Report First Quarter 2025 Financial Results on May 8, 2025NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain...